In addition to MDS and AML20, CK1α was also found to promote survival of lymphoma cells21, as well as a variety of solid tumors such as in lung22, renal23, and colorectal24 cancers, suggesting a potential broader clinical application of compounds that influence CK1α levels or activity. Here, CSNK1A1 is linked to myelodysplastic syndrome.